The Cuban Center for Molecular Immunology and the Roswell Park Cancer Institute in New York on Tuesday signed an agreement to export to the USA a lung cancer vaccine developed on the island.»

The registration of the Cuban vaccine RACOTUMOMAB, for the treatment of advanced lung cancer, was the most significant result of 2012 for the Molecular Immunology Center (CIM).»

The Molecular Immunology Center of Cuba (CIM) has just patented a new therapeutic vaccine for the treatment of lung cancer, said Ana Maria Vazquez, a specialist of that institution.»